$1.32
7.04% yesterday
Nasdaq, Dec 02, 10:07 pm CET
ISIN
US64131A1051
Symbol
STIM

Neuronetics, Inc. Stock price

$1.32
-1.45 52.35% 1M
-2.49 65.35% 6M
-0.29 18.01% YTD
+0.21 18.92% 1Y
-4.87 78.68% 3Y
-6.52 83.16% 5Y
-26.46 95.25% 10Y
-26.46 95.25% 20Y
Nasdaq, Closing price Tue, Dec 02 2025
-0.10 7.04%

Key metrics

Basic
Market capitalization
$90.4m
Enterprise Value
$128.1m
Net debt
$37.7m
Cash
$28.0m
Shares outstanding
68.5m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.7 | 0.6
EV/Sales
1.0 | 0.8
EV/FCF
negative
P/B
3.3
Financial Health
Equity Ratio
19.7%
Return on Equity
-157.8%
ROCE
-32.5%
ROIC
-
Debt/Equity
2.4
Financials (TTM | estimate)
Revenue
$129.9m | $154.1m
EBITDA
$-34.7m | $-21.0m
EBIT
$-37.9m | $-30.5m
Net Income
$-44.5m | $-40.0m
Free Cash Flow
$-30.6m
Growth (TTM | estimate)
Revenue
78.6% | 105.7%
EBITDA
-36.7% | 26.3%
EBIT
-37.6% | 0.2%
Net Income
-22.2% | 8.4%
Free Cash Flow
-35.6%
Margin (TTM | estimate)
Gross
50.4%
EBITDA
-26.7% | -13.6%
EBIT
-29.2%
Net
-34.3% | -26.0%
Free Cash Flow
-23.5%
More
EPS
$-0.7
FCF per Share
$-0.4
Short interest
16.4%
Employees
716
Rev per Employee
$100.0k
Show more

Is Neuronetics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,084 stocks worldwide.

Neuronetics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Neuronetics, Inc. forecast:

8x Buy
89%
1x Hold
11%

Analyst Opinions

9 Analysts have issued a Neuronetics, Inc. forecast:

Buy
89%
Hold
11%

Financial data from Neuronetics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
130 130
79% 79%
100%
- Direct Costs 64 64
264% 264%
50%
66 66
19% 19%
50%
- Selling and Administrative Expenses 93 93
26% 26%
71%
- Research and Development Expense 6.69 6.69
27% 27%
5%
-35 -35
37% 37%
-27%
- Depreciation and Amortization 3.14 3.14
47% 47%
2%
EBIT (Operating Income) EBIT -38 -38
38% 38%
-29%
Net Profit -45 -45
22% 22%
-34%

In millions USD.

Don't miss a Thing! We will send you all news about Neuronetics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Neuronetics, Inc. Stock News

Neutral
GlobeNewsWire
13 days ago
MALVERN, Pa., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc., (NASDAQ: STIM) (the “Company” or “Neuronetics”) a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the leading neurohealth therapies in the world, today announced that the management team wil...
Neutral
GlobeNewsWire
21 days ago
New Policy Update Brings Innovative, Non-Drug Depression Treatment to Adolescents Across 26 States New Policy Update Brings Innovative, Non-Drug Depression Treatment to Adolescents Across 26 States
Neutral
Seeking Alpha
29 days ago
Neuronetics, Inc. ( STIM ) Q3 2025 Earnings Call November 4, 2025 8:30 AM EST Company Participants Keith Sullivan - President, CEO & Director Steven Pfanstiel - Executive VP, Treasurer & CFO Conference Call Participants Mark Klausner - Westwicke Partners, LLC William Plovanic - Canaccord Genuity Corp., Research Division Kyle Edward Winborne - Piper Sandler & Co., Research Division Daniel Staude...
More Neuronetics, Inc. News

Company Profile

Neuronetics, Inc. commercial stage medical technology company. It focuses on designing, developing and marketing products for the patients suffering from psychiatric disorders. The firm offers NeuroStar TMS, a therapy system for the treatment of major depressive disorders in adult patients. It also provides a range of support services, including patient education, practice data management system, and customer and technical services to help the client start and manage TMS therapy systems. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon and Thomas D. Weldon in April 2003 and is headquartered in Malvern, PA.

Head office United States
CEO Keith Sullivan
Employees 716
Founded 1998
Website neurostar.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today